|
|||||
|
|
Efficacy,Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized,Double-Blind,Placebo-Controlled Study |
|
| Authors: | Richard B. Lipton MD Sagar Munjal MD Elimor Brand-Schieber PhD Stewart J. Tepper MD David W. Dodick MD |
| Affiliation: | 1. Albert Einstein College of Medicine, Bronx, NY, USA;2. Dr. Reddy’s Laboratories, Princeton, NJ, USA;3. Geisel School of Medicine at Dartmouth, Hanover, NH, USA;4. Mayo Clinic, Scottsdale, AZ, USA |
| Abstract: | |
| Keywords: | migraine acute treatment nonsteroidal anti-inflammatory drug oral celecoxib |